Merck
MRK
#40
Rank
NZ$621.80 B
Marketcap
NZ$252.23
Share price
-3.32%
Change (1 day)
53.60%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): NZ$1.78

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$1.81. In 2025 the company made an earnings per share (EPS) of NZ$13.30 an increase over its 2024 EPS that were of NZ$12.30.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.78-86.65%
2025NZ$13.308.15%
2024NZ$12.304308.46%
2023NZ$0.28-97.32%
2022NZ$10.4310.92%
2021NZ$9.4084.68%
2020NZ$5.09-27.2%
2019NZ$6.9963.44%
2018NZ$4.28151.11%
2017NZ$1.70-54.58%
2016NZ$3.7530.21%
2015NZ$2.88-61.99%
2014NZ$7.58180.51%
2013NZ$2.70-31.82%
2012NZ$3.966.62%
2011NZ$3.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16 572.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.55 428.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.29-28.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.92 172.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.21 3,010.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.63 1,650.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.60 99.44%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.23 355.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.24 189.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$0.82-54.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel